These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 841677)

  • 1. Rapid in vivo destruction of Yt(a+) erythrocytes in a recipient with anti-Yta.
    Ballas SK; Sherwood WC
    Transfusion; 1977; 17(1):65-6. PubMed ID: 841677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 51Chromium survival of Yt(a+) red cells as a determinant of the in vivo significance of anti-Yta.
    Davey RJ; Simpkins SS
    Transfusion; 1981; 21(6):702-5. PubMed ID: 7314218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell transfusion in patients with anti-Yt
    Wong SM; Cawthorne T; Dennington PM; Hong FS
    Transfusion; 2021 Feb; 61(2):379-384. PubMed ID: 33410173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transfusion policy toward a patient with an anti-Cartwright antibody (anti-Yta)].
    Arriaga F; García R; Guinot M; de la Rubia J; García M; Bonanad S; Marty ML
    Sangre (Barc); 1993 Aug; 38(4):327-9. PubMed ID: 8235948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chemiluminescence test for predicting the outcome of transfusing incompatible blood.
    Hadley A; Wilkes A; Poole J; Arndt P; Garratty G
    Transfus Med; 1999 Dec; 9(4):337-42. PubMed ID: 10583888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with anti-Cartwright (Yta).
    Mohandas K; Spivack M; Delehanty CL
    Transfusion; 1985; 25(4):381-4. PubMed ID: 4024238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of anti-Yta antibody in a Yt(a+) patient.
    Mazzi G; Raineri A; Santarossa L; De Roia D; Orazi BM
    Vox Sang; 1994; 66(2):130-2. PubMed ID: 8184594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A second example of anti-Yta with rapid in vivo destruction of Yt(a plus) red cells.
    Göbel U; Drescher KH; Pöttgen W; Lehr HJ
    Vox Sang; 1974; 27(2):171-5. PubMed ID: 4850290
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic and IgG subclass characterization of Cartwright (Yt) and Gerbich (Ge) antibodies.
    Vengelen-Tyler V; Morel PA
    Transfusion; 1983; 23(2):114-6. PubMed ID: 6836689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical case of alloimmunization with a rare anti-Cartwright antibody associated with anti-Kidd antibody].
    Mattoni C; Salvetti E; Molinatti M
    Ann Osp Maria Vittoria Torino; 1991; 32(7-12):196-201. PubMed ID: 1810174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human erythrocyte acetylcholinesterase bears the Yta blood group antigen and is reduced or absent in the Yt(a-b-) phenotype.
    Rao N; Whitsett CF; Oxendine SM; Telen MJ
    Blood; 1993 Feb; 81(3):815-9. PubMed ID: 8427972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the Cartwright (Yt) blood group system.
    George MR
    Immunohematology; 2019 Dec; 35(4):154-155. PubMed ID: 31935332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of anti-Yt(b). Report of a case using a 51chromium red cell survival study.
    Levy GJ; Selset G; McQuiston D; Nance SJ; Garratty G; Smith LE; Goldfinger D
    Transfusion; 1988; 28(3):265-7. PubMed ID: 3285526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion.
    Weinstock C; Möhle R; Dorn C; Weisel K; Höchsmann B; Schrezenmeier H; Kanz L
    Transfusion; 2015 Mar; 55(3):605-10. PubMed ID: 25251967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Cob causing acute hemolytic transfusion reaction.
    Lee EL; Bennett C
    Transfusion; 1982; 22(2):159-60. PubMed ID: 7071920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shortened long-term survival of incompatible red cells in a patient with anti-McCoy-like antibody. Immunoglobulin characteristics of this antibody.
    Gandhi JG; Moulds JJ; Szymanski IO
    Transfusion; 1984; 24(1):16-8. PubMed ID: 6695434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase.
    Spring FA; Gardner B; Anstee DJ
    Blood; 1992 Oct; 80(8):2136-41. PubMed ID: 1391965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Normal survival in vivo of Yt (a+) red blood cells in a patient with anti-Yta].
    Serrano J; Paniagua C; Sánchez Fayos J; Outeiriño J; Calabuig T; Escudero A
    Sangre (Barc); 1986; 31(6):768-71. PubMed ID: 3563836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.